# OnCo record paper-dang-nat-rev-cancer (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-dang-nat-rev-cancer/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-dang-nat-rev-cancer" ;
  schema:name "Drugging the 'undruggable' cancer targets"@en ;
  schema:description "Paper cited by one bottleneck page and 24 idea pages, indexed on Europe PMC as PubMed record 28643779 and published in Nature Reviews Cancer; the citing pages link this DOI, which is how the record was matched."@en ;
  schema:url <https://onco.cc/key-papers/paper-dang-nat-rev-cancer/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://doi.org/10.1038/nrc.2017.36>, <https://pubmed.ncbi.nlm.nih.gov/28643779/>, <https://europepmc.org/article/MED/28643779> ;
  onco:tag "europepmc-ingest" ;
  schema:sameAs <https://doi.org/10.1038/nrc.2017.36> ;
  schema:datePublished "2017"^^xsd:gYear ;
  schema:author "Dang CV, Reddy EP, Shokat KM, et al." ;
  onco:related <https://onco.cc/bottlenecks/b-undruggable-targets/>, <https://onco.cc/ideas/idea-bio1-undruggable-market-commitment/>, <https://onco.cc/ideas/idea-bio1-ai-binders-disordered-regions/>, <https://onco.cc/ideas/idea-bio1-covalent-ligandability-atlas/>, <https://onco.cc/ideas/idea-bio1-pmhc-bispecifics-public-drivers/>, <https://onco.cc/ideas/idea-bio1-paralog-synthetic-lethality/>, <https://onco.cc/ideas/idea-bio1-condensate-disruptors/>, <https://onco.cc/ideas/idea-bio1-pan-ras-covalent-g12d/>, <https://onco.cc/ideas/idea-bio1-mutant-p53-degrader/>, <https://onco.cc/ideas/idea-bio1-fusion-tf-degraders/>, <https://onco.cc/ideas/idea-bio1-arv7-degrader/>, <https://onco.cc/ideas/idea-bio1-lytac-surface-degraders/>, <https://onco.cc/ideas/idea-bio1-p53-mutant-reactivator-expansion/>, <https://onco.cc/ideas/idea-bio1-tumour-restricted-e3-atlas/>, <https://onco.cc/ideas/idea-bio1-mrna-intrabodies/>, <https://onco.cc/ideas/idea-bio1-macrocycle-ppi-campaign/>, <https://onco.cc/ideas/idea-bio1-myc-max-molecular-glue/>, <https://onco.cc/ideas/idea-bio1-omomyc-mrna/>, <https://onco.cc/ideas/idea-bio1-glue-degrader-atlas/>, <https://onco.cc/ideas/idea-bio1-rna-targeting-small-molecules/>, <https://onco.cc/ideas/idea-bio1-translation-dependency-myc/>, <https://onco.cc/ideas/idea-bio1-epigenetic-silencing-in-vivo/>, <https://onco.cc/ideas/idea-bio1-pp2a-activators/>, <https://onco.cc/ideas/idea-bio1-antibody-degrader-conjugates/>, <https://onco.cc/ideas/idea-bio1-wrn-msi-programme/> ;
  onco:journals <https://onco.cc/journals/nature-reviews-cancer/> .